Make prescribing decisions with our comparative charts and treatment algorithms.
Download or print easy-to-read disease leaflets for your patients.
Atriphen has been recalled due to the possibility of causing a severe allergic reaction from two undeclared allergens.
The FDA has accepted for review the Biologics License Application for ragweed pollen sublingual allergy immunotherapy tablet.
Parental sucking of their infant's pacifier is associated with a reduced risk of allergy development.
For U.S. children aged younger than 18 years, the prevalence of allergies increased from 1997-2011, with age, race/ethnicity, and income all affecting the prevalence.